Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

NCT05451771 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Venetoclax Oral Tablet, 200 mg
DEVICE: FISH assay
DRUG: Venetoclax Oral Tablet, 400 mg
DRUG: Dexamethasone Oral, 10 mg
DRUG: Dexamethasone Oral, 20 mg
DRUG: Daratumumab Injection
DRUG: Bendamustine
DRUG: Pomalidomide
DRUG: Ixazomib
DRUG: Venetoclax MTD with Dexamethasone

Sponsor

Rajshekhar Chakraborty, MD

Collaborators

[object Object]